ASH 2021 Conference Coverage on VuMedi
ASH 2021 Update on a Phase II Study of OB-VEN in Patients With HTB-FL as 1L Therapy
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Craig Portell
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Craig Portell
Login to view comments.
Click here to Login
